These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 229713)
41. Evaluation of a kinetic assay for angiotensin converting enzyme. Wong YW; Kinniburgh DW Clin Biochem; 1987 Oct; 20(5):323-7. PubMed ID: 2826049 [TBL] [Abstract][Full Text] [Related]
42. Inhibition by FOY of kininase II in human plasma. Bönner G; Frericks A; Büchsler U; Kaufmann W Biol Chem Hoppe Seyler; 1986 Sep; 367(9):963-8. PubMed ID: 3024668 [TBL] [Abstract][Full Text] [Related]
43. Species differences in the angiotensin converting enzyme activity of mammalian serum. Kase R; Hazato T; Kiuchi Y; Katayama T Jikken Dobutsu; 1986 Jan; 35(1):107-8. PubMed ID: 3011465 [TBL] [Abstract][Full Text] [Related]
44. Method for measurement of human urinary kininase activity. Porcelli G; Di Jorio M; Ranieri M; Ranalli L; D'Acquarica L Adv Exp Med Biol; 1979; 120A():143-5. PubMed ID: 227241 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of kininase II (angiotensin I converting enzyme) by human serum albumin and its fragments. Klauser RJ; Robinson CJ; Erdös EG Adv Exp Med Biol; 1979; 120B():477-85. PubMed ID: 229711 [No Abstract] [Full Text] [Related]
48. Urinary ACE Phenotyping as a Research and Diagnostic Tool: Identification of Sex-Dependent ACE Immunoreactivity. Kozuch AJ; Petukhov PA; Fagyas M; Popova IA; Lindeblad MO; Bobkov AP; Kamalov AA; Toth A; Dudek SM; Danilov SM Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979933 [TBL] [Abstract][Full Text] [Related]
49. Breakthrough: a first-in-class virtual simulator for dose optimization of ACE inhibitors in translational cardiovascular medicine. Schneider BK; Ward J; Sotillo S; Garelli-Paar C; Guillot E; Prikazsky M; Mochel JP Sci Rep; 2023 Feb; 13(1):3300. PubMed ID: 36843132 [TBL] [Abstract][Full Text] [Related]
50. Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart. Bánhegyi V; Enyedi A; Fülöp GÁ; Oláh A; Siket IM; Váradi C; Bottyán K; Lódi M; Csongrádi A; Umar AJ; Fagyas M; Czuriga D; Édes I; Pólos M; Merkely B; Csanádi Z; Papp Z; Szabó G; Radovits T; Takács I; Tóth A Cells; 2021 Jul; 10(7):. PubMed ID: 34359878 [No Abstract] [Full Text] [Related]
52. New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human. Fagyas M; Úri K; Siket IM; Fülöp GÁ; Csató V; Daragó A; Boczán J; Bányai E; Szentkirályi IE; Maros TM; Szerafin T; Édes I; Papp Z; Tóth A PLoS One; 2014; 9(4):e87844. PubMed ID: 24691203 [TBL] [Abstract][Full Text] [Related]
53. New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition. Fagyas M; Úri K; Siket IM; Daragó A; Boczán J; Bányai E; Édes I; Papp Z; Tóth A PLoS One; 2014; 9(4):e87843. PubMed ID: 24691160 [TBL] [Abstract][Full Text] [Related]
54. New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases. Fagyas M; Úri K; Siket IM; Daragó A; Boczán J; Bányai E; Édes I; Papp Z; Tóth A PLoS One; 2014; 9(4):e93719. PubMed ID: 24690767 [TBL] [Abstract][Full Text] [Related]
57. Mammalian inhibitors of angiotensin converting enzyme (kininase II). Ryan JW; Martin LC; Chung A; Pena GA Adv Exp Med Biol; 1979; 120B():599-606. PubMed ID: 229713 [TBL] [Abstract][Full Text] [Related]
58. A comparison of guinea pig serum angiotensin converting enzyme with forms of angiotensin converting enzyme from human, rat and rabbit tissues. Ryan JW; Valido FA; Chung AY; Ripka JE; Peterson CM; Urry RL Biochem Biophys Res Commun; 1993 Oct; 196(2):509-14. PubMed ID: 8240321 [TBL] [Abstract][Full Text] [Related]
59. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries. Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724 [TBL] [Abstract][Full Text] [Related]
60. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme). Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]